TERT polymorphisms modify the risk of acute lymphoblastic leukemia in chinese children

Carcinogenesis

Volumn 34, Issue 1, 2013, Pages 228-235

  Sheng, Xiaojing ^a,b   Tong, Na ^c   Tao, Guoquan ^d   Luo, Dewei ^c   Wang, Meilin ^c   Fang, Yongjun ^e   Li, Jie ^f   Xu, Ming ^c   Zhang, Zhengdong ^a,c   Wu, Dongmei ^a,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Nanjing Medical University   (China)

^d THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^f CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHILD; CHILDHOOD CANCER; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFANT; INTRON; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; CHINA; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REAL-TIME POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 84872145398     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs325     Document Type: Article

References (51)

1. Pui, C.H. et al. (1998) Acute lymphoblastic leukemia. N. Engl. J. Med., 339, 605-615.
2. Belson, M. et al. (2007) Risk factors for acute leukemia in children: a review. Environ. Health Perspect., 115, 138-145.
3. Liu, R. et al. (2011) Paternal smoking and risk of childhood acute lymphoblastic leukemia: systematic review and meta-analysis. J. Oncol., 2011, 854584.
4. Capraro, V. et al. (2011) Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Exp. Hematol., 39, 195-202.e2.
5. Murnane, J.P. (2006) Telomeres and chromosome instability. DNA Repair, 5, 1082-1092.
6. Donate, L.E. et al. (2011) Telomeres in cancer and ageing. Philos. Trans. R. Soc. Lond., B, Biol. Sci., 366, 76-84.
7. Blackburn, E.H. (2001) Switching and signaling at the telomere. Cell, 106, 661-673.
8. Takakura, M. et al. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res., 59, 551-557.
9. Zvereva, M.I. et al. (2010) Telomerase: structure, functions, and activity regulation. Biochemistry, 75, 1563-1583.
10. Londoño-Vallejo, J.A. et al. (2004) Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res., 64, 2324-2327.
11. Catarino, R. et al. (2010) Prognostic significance of telomerase polymorphism in non-small cell lung cancer. Clin. Cancer Res., 16, 3706-3712.
12. Wentzensen, I.M. et al. (2011) The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 20, 1238-1250.
13. Ma, H. et al. (2011) Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE, 6, e20466.
14. Kleideiter, E. et al. (2005) Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL). Leukemia, 19, 296-298.
15. Wick, M. et al. (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene, 232, 97-106.
16. Nakamura, T.M. et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959.
17. Turnbull, C. et al. (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat. Genet., 42, 604-607.
18. McKay, J.D. et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
19. Landi, M.T. et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet., 85, 679-691.
20. Shete, S. et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet., 41, 899-904.
21. Rafnar, T. et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-227.
22. Hu, Z. et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet., 43, 792-796.
23. Kote-Jarai, Z. et al. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet., 43, 785-791.
24. Haiman, C.A. et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet., 43, 1210-1214.
25. Kratz, C.P. et al. (2011) Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J. Med. Genet., 48, 473-476.
26. Tong, N. et al. (2010) Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci., 101, 782-786.
27. Li, Q. et al. (2011) hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci., 102, 1123-1127.
28. Barrett, J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
29. Terme, J.M. et al. (2009) Inhibition of the hTERT promoter by the protooncogenic protein TAL1. Leukemia, 23, 2081-2089.
30. Kim, N.W. et al. (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res., 25, 2595-2597.
31. Boldrini, L. et al. (2006) Telomerase activity and hTERT mRNA expression in glial tumors. Int. J. Oncol., 28, 1555-1560.
32. Cawthon, R.M. (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res., 30, e47.
33. Sheng, X. et al. (2012) A common variant near TERC and telomere length are associated with susceptibility to childhood acute lymphoblastic leukemia in Chinese. Leuk Lymphoma, 53, 1688-1692.
34. Weinrich, S.L. et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet., 17, 498-502.
35. Kim, N.W. et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
36. Wang, Y. et al. (2010) Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival. Int. J. Lab. Hematol., 32, 230-238.
37. Hills, M. et al. (2009) Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies. Ann. N. Y. Acad. Sci., 1176, 178-190.
38. Matsubara, Y. et al. (2006) Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem. Biophys. Res. Commun., 341, 128-131.
39. Nordfjäll, K. et al. (2007) hTERT (-1327)T/C polymorphism is not associated with age-related telomere attrition in peripheral blood. Biochem. Biophys. Res. Commun., 358, 215-218.
40. Yi, X. et al. (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res., 29, 4818-4825.
41. Beesley, J. et al. (2011) Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS ONE, 6, e24987.
42. Taylor, J. et al. (2006) ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res., 16, 1596-1604.
43. Mocellin, S. et al. (2012) Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J. Natl. Cancer Inst., 104, 840-854.
44. Perona, R. et al. (2009) Telomerase deficiency and cancer susceptibility syndromes. Clin. Transl. Oncol., 11, 711-714.
45. Yang, J.J. et al. (2009) Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA, 301, 393-403.
46. Papaemmanuil, E. et al. (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat. Genet., 41, 1006-1010.
47. Treviño, L.R. et al. (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat. Genet., 41, 1001-1005.
48. Sherborne, A.L. et al. (2010) Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat. Genet., 42, 492-494.
49. Ellinghaus, E. et al. (2012) Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia, 26, 902-909.
50. Han, S. et al. (2010) Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk. Res., 34, 1271-1274.
51. Lee, P. et al. (2011) Fine mapping of 14q24.1 breast cancer susceptibility locus. Hum Genet., 131, 479-490